CYAD - セリアド （Celyad SA） セリアドCYADのチャート
CYADの企業情報
| symbol | CYAD |
|---|---|
| 会社名 | Celyad SA （セリアド） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | ― 医療関連（Health Care） |
| 概要 | 事業概要 -- セリアドはベルギ―のバイオ医薬品企業。主に心不全や心筋梗塞などの心臓疾患の治療法の発見、開発、商業化に従事する。バイオ治療薬を心臓の筋肉に注入するためのカテ―テル「C-CATHez」を提供。また、慢性心不全や虚血性心筋症の治療向けに臨床段階の主力薬剤である「C-Cure」を提供する。新薬候補にはタンパク質ベ―スの薬剤も扱う。 |
| 本社所在地 | Rue Edouard Belin 12 Mont-Saint-Guibert 1435 BEL |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | 39264 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2015年 |
| 従業員数 | 76人 |
| url | www.C3BS.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cyad |
| adr_tso | 883561 |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 25 |
| 時価総額（marketcap） | 22089025 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
CYADのテクニカル分析
CYADのニュース
Celyad plans to delist from Nasdaq amid cash woes 2023/05/05 09:40:29 Seeking Alpha
Celyad Oncology (CYAD) is delisting its American Depositary Shares (ADSs) from Nasdaq. Read more here
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session 2023/03/16 17:56:50 Benzinga
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO ) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for hemorrhagic cystitis. PureCycle Technologies, Inc. (NASDAQ: PCT ) rose 31.8% to $6.29 after the company issued Q4 update. ThermoGenesis Holdings, Inc. (NASDAQ: THMO ) shares jumped 30.7% to $5.48. ThermoGenesis shares jumped around 99% on Wednesday after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. Science 37 Holdings, Inc. (NASDAQ: SNCE ) gained 27.1% to $0.3083. EverCommerce Inc. (NASDAQ: EVCM ) jumped 21.2% to $10.86 following Q4 results. Wejo Group Limited (NASDAQ: WEJO ) gained 17.7% to $0.4001. Verde Clean Fuels, Inc. (NASDAQ: VGAS ) jumped 17.1% to $9.25. Celyad Oncology SA (NASDAQ: CYAD ) gained 16.1% to $0.9599. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.
Celyad slumps ~30% as board to put proposal to continue activities on vote at shareholders'' meet 2023/03/15 09:33:18 Seeking Alpha
Celyad Oncology (CYAD) said it will recognize a non-cash impairment of its goodwill and intangible oncology assets and that its board plans to submit for a vote its business plan…
Celyad Oncology Announces Non-Cash Impairment 2023/03/15 06:00:00 Wallstreet:Online
Regulatory News: Celyad Oncology (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today announced a non-cash impairment of its goodwill and intangible oncology assets. This impairment comes as a result of
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday''s Mid-Day Session 2023/02/17 17:26:01 Benzinga
Gainers Ibio Inc (NYSE: IBIO ) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. Universal Security Instruments, Inc. (NYSE: UUU ) rose 40.6% to $3.09 after the company reported a year-over-year increase in Q3 EPS and revenues. SciSparc Ltd. (NASDAQ: SPRC ) gained 25.4% to $1.1410 after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement. Cyclo Therapeutics, Inc. (NASDAQ: CYTH ) surged 22.4% to $1.3952. AMC Networks Inc. (NASDAQ: AMCX ) shares jumped 20.9% to $24.60 after reporting better-than-expected Q4 results. EBET, Inc. (NASDAQ: EBET ) gained 18.4% to $0.6321 following strong Q4 results and guidance from DraftKings. Apexigen, Inc. (NASDAQ: APGN ) jumped 15.8% to $1.10. Telephone and Data Systems, Inc. (NYSE: TDS ) rose 15% to $12.80 after the company posted Q4 results and increased its common share dividend from $0.18 to $0.185.
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session 2023/03/16 17:56:50 Benzinga
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO ) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for hemorrhagic cystitis. PureCycle Technologies, Inc. (NASDAQ: PCT ) rose 31.8% to $6.29 after the company issued Q4 update. ThermoGenesis Holdings, Inc. (NASDAQ: THMO ) shares jumped 30.7% to $5.48. ThermoGenesis shares jumped around 99% on Wednesday after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. Science 37 Holdings, Inc. (NASDAQ: SNCE ) gained 27.1% to $0.3083. EverCommerce Inc. (NASDAQ: EVCM ) jumped 21.2% to $10.86 following Q4 results. Wejo Group Limited (NASDAQ: WEJO ) gained 17.7% to $0.4001. Verde Clean Fuels, Inc. (NASDAQ: VGAS ) jumped 17.1% to $9.25. Celyad Oncology SA (NASDAQ: CYAD ) gained 16.1% to $0.9599. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.
Celyad slumps ~30% as board to put proposal to continue activities on vote at shareholders'' meet 2023/03/15 09:33:18 Seeking Alpha
Celyad Oncology (CYAD) said it will recognize a non-cash impairment of its goodwill and intangible oncology assets and that its board plans to submit for a vote its business plan…
Celyad Oncology Announces Non-Cash Impairment 2023/03/15 06:00:00 Wallstreet:Online
Regulatory News: Celyad Oncology (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today announced a non-cash impairment of its goodwill and intangible oncology assets. This impairment comes as a result of
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday''s Mid-Day Session 2023/02/17 17:26:01 Benzinga
Gainers Ibio Inc (NYSE: IBIO ) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. Universal Security Instruments, Inc. (NYSE: UUU ) rose 40.6% to $3.09 after the company reported a year-over-year increase in Q3 EPS and revenues. SciSparc Ltd. (NASDAQ: SPRC ) gained 25.4% to $1.1410 after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement. Cyclo Therapeutics, Inc. (NASDAQ: CYTH ) surged 22.4% to $1.3952. AMC Networks Inc. (NASDAQ: AMCX ) shares jumped 20.9% to $24.60 after reporting better-than-expected Q4 results. EBET, Inc. (NASDAQ: EBET ) gained 18.4% to $0.6321 following strong Q4 results and guidance from DraftKings. Apexigen, Inc. (NASDAQ: APGN ) jumped 15.8% to $1.10. Telephone and Data Systems, Inc. (NYSE: TDS ) rose 15% to $12.80 after the company posted Q4 results and increased its common share dividend from $0.18 to $0.185.
Cyclo, Celyad top healthcare gainers; VolitionRx, Applied Therapeutics among losers 2023/02/17 15:01:06 Seeking Alpha
Cyclo Therapeutics (CYTH) +19%. Celyad Oncology (CYAD) +16%. VolitionRx VNRX -12%. Applied Therapeutics (APLT) -11%.
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session 2023/03/16 17:56:50 Benzinga
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO ) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for hemorrhagic cystitis. PureCycle Technologies, Inc. (NASDAQ: PCT ) rose 31.8% to $6.29 after the company issued Q4 update. ThermoGenesis Holdings, Inc. (NASDAQ: THMO ) shares jumped 30.7% to $5.48. ThermoGenesis shares jumped around 99% on Wednesday after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. Science 37 Holdings, Inc. (NASDAQ: SNCE ) gained 27.1% to $0.3083. EverCommerce Inc. (NASDAQ: EVCM ) jumped 21.2% to $10.86 following Q4 results. Wejo Group Limited (NASDAQ: WEJO ) gained 17.7% to $0.4001. Verde Clean Fuels, Inc. (NASDAQ: VGAS ) jumped 17.1% to $9.25. Celyad Oncology SA (NASDAQ: CYAD ) gained 16.1% to $0.9599. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.
Celyad slumps ~30% as board to put proposal to continue activities on vote at shareholders'' meet 2023/03/15 09:33:18 Seeking Alpha
Celyad Oncology (CYAD) said it will recognize a non-cash impairment of its goodwill and intangible oncology assets and that its board plans to submit for a vote its business plan…
Celyad Oncology Announces Non-Cash Impairment 2023/03/15 06:00:00 Wallstreet:Online
Regulatory News: Celyad Oncology (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today announced a non-cash impairment of its goodwill and intangible oncology assets. This impairment comes as a result of
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday''s Mid-Day Session 2023/02/17 17:26:01 Benzinga
Gainers Ibio Inc (NYSE: IBIO ) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. Universal Security Instruments, Inc. (NYSE: UUU ) rose 40.6% to $3.09 after the company reported a year-over-year increase in Q3 EPS and revenues. SciSparc Ltd. (NASDAQ: SPRC ) gained 25.4% to $1.1410 after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement. Cyclo Therapeutics, Inc. (NASDAQ: CYTH ) surged 22.4% to $1.3952. AMC Networks Inc. (NASDAQ: AMCX ) shares jumped 20.9% to $24.60 after reporting better-than-expected Q4 results. EBET, Inc. (NASDAQ: EBET ) gained 18.4% to $0.6321 following strong Q4 results and guidance from DraftKings. Apexigen, Inc. (NASDAQ: APGN ) jumped 15.8% to $1.10. Telephone and Data Systems, Inc. (NYSE: TDS ) rose 15% to $12.80 after the company posted Q4 results and increased its common share dividend from $0.18 to $0.185.